83 related articles for article (PubMed ID: 2783556)
1. Induction of colony-stimulating activity in mice by injection of liposomes containing lipophilic muramyl peptide derivatives.
Galelli A; Charlot B; Phillips NC; Chedid L
Cancer Res; 1989 Feb; 49(4):810-5. PubMed ID: 2783556
[TBL] [Abstract][Full Text] [Related]
2. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
[TBL] [Abstract][Full Text] [Related]
3. Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).
Phillips NC; Moras ML; Chedid L; Petit JF; Tenu JP; Lederer E; Bernard JM; Lefrancier P
J Biol Response Mod; 1985 Oct; 4(5):464-74. PubMed ID: 3935756
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
Phillips NC; Tsao MS
Cancer Res; 1989 Feb; 49(4):936-9. PubMed ID: 2912563
[TBL] [Abstract][Full Text] [Related]
5. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
6. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
Schroit AJ; Fidler IJ
Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
[TBL] [Abstract][Full Text] [Related]
7. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of macrophages by muroctasin to produce colony-stimulating factors.
Akahane K; Yamaguchi F; Kita Y; Une T; Osada Y
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):179-83. PubMed ID: 1692219
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptide.
Brodt P; Blore J; Phillips NC; Munzer JS; Rioux JD
Cancer Immunol Immunother; 1989; 28(1):54-8. PubMed ID: 2909283
[TBL] [Abstract][Full Text] [Related]
11. Induction of colony-stimulating activity (CSA) by a synthetic muramyl peptide (MDP): synergism with LPS and activity in C3H/HeJ mice and in endotoxin-tolerized mice.
Galelli A; Chedid L
J Immunol; 1986 Nov; 137(10):3211-5. PubMed ID: 3490515
[TBL] [Abstract][Full Text] [Related]
12. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of human endothelial cells by synthetic muramyl peptides: production of colony-stimulating activity (CSA).
Galelli A; Dosne AM; Morin A; Dubor F; Chedid L
Exp Hematol; 1985 Dec; 13(11):1157-63. PubMed ID: 3877645
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell binding and induction of endothelial cell tumoricidal activity in vitro by muramyl dipeptide is enhanced by liposomal encapsulation.
Phillips NC; Stewart-Phillips J; Wang P
J Immunother Emphasis Tumor Immunol; 1994 Apr; 15(3):185-93. PubMed ID: 8032541
[TBL] [Abstract][Full Text] [Related]
15. Modulation of natural killer activity by muramyl peptides: relationship with adjuvant and anti-infectious properties.
Le Garrec Y; Morin A
Nat Immun Cell Growth Regul; 1987; 6(2):65-76. PubMed ID: 2439906
[TBL] [Abstract][Full Text] [Related]
16. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin.
Yamaguchi F; Akasaki M; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):980-3. PubMed ID: 3263869
[TBL] [Abstract][Full Text] [Related]
17. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
Sone S; Mutsuura S; Ogawara M; Tsubura E
J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivatives.
Merhi G; Coleman AW; Devissaguet JP; Barratt GM
J Med Chem; 1996 Oct; 39(22):4483-8. PubMed ID: 8893843
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated antigens as immunotherapy targets.
Phillips NC; Major PP; Sikorska H
Cancer Detect Prev; 1988; 12(1-6):451-9. PubMed ID: 3263200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
